Human medicines European public assessment report (EPAR): Eribulin Baxter, eribulin, Date of authorisation: 27/06/2024, Revision: 2, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 24 February 2026 - 14:10

Human medicines European public assessment report (EPAR): Eribulin Baxter, eribulin, Date of authorisation: 27/06/2024, Revision: 2, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/eribulin-baxter

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters